Education, Science, Technology, Innovation and Life
Open Access
Sign In

Mechanism of Early Atherosclerosis in Systemic Lupus Erythematosus

Download as PDF

DOI: 10.23977/phpm.2023.030210 | Downloads: 10 | Views: 387

Author(s)

Caimei Wang 1, Lanke Xu 2, Xiaoling Liu 3, Jinhuan Deng 1, Guofei Mao 1, Yi Sun 2

Affiliation(s)

1 Department of Laboratory Medicine, Affiliated Hospital of Guilin Medical College, Guilin, 541001, China
2 Guilin Medical College, Guilin, 541000, China
3 Department of Endocrinology, Affiliated Hospital of Guilin Medical College, Guilin, 541001, China

Corresponding Author

Xiaoling Liu

ABSTRACT

Systemic lupus erythematosus (SLE) is a diffuse connective tissue disease characterized by immune inflammation, which often has multiple system involvement. The late cause of death is coronary atherosclerosis (AS) and its complications. Early atherosclerosis in SLE patients may be related to related microvascular damage and dysfunction caused by long-term immune disorders and lipid metabolism disorders.

KEYWORDS

Systemic Lupus Erythematosus; Atherosclerosis; Disorder of Lipid Metabolism; Immune Mechanism

CITE THIS PAPER

Caimei Wang, Lanke Xu, Xiaoling Liu, Jinhuan Deng, Guofei Mao, Yi Sun, Mechanism of Early Atherosclerosis in Systemic Lupus Erythematosus. MEDS Public Health and Preventive Medicine (2023) Vol. 3: 74-78. DOI: http://dx.doi.org/10.23977/phpm.2023.030210.

REFERENCES

[1] Tselios K1, Gladman DD, Sheane BJ, et al. All-cause, cause-specific and age-spec-ific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013)[J]. Ann Rheum Dis. 2019, 78(6):802-806.  
[2] Guidelines for diagnosis and treatment of systemic lupus erythematosus, Rheumatology Branch of Chinese Medical Association, Chinese Journal of Rheumatology, 2010, 14 (5) 342-346. 
[3] Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atheroscler-osis in systemic lupus erythematosus[J]. N En-gl J Med, 2003, 349(25): 2407-2415. 
[4] Hao Yanjie, Dong Yi, Zhang Zhuoli, et al. Study on risk factors of subclinical atherosclerosis in systemic lupus erythematosus [J]. Chinese Journal of Rheumatology, 2009, 13 (12): 816-818. 
[5] Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk fac-tors of carotid plaque in women with systemic lupus erythematosus[J]. Arthritis Rheum, 1999, 42(1):51-60. 
[6] AI Husain A, Bruce IN. Risk factors for coronary heart disease in connective tis-suedisease[J]. Ther Adv Musculoskel Dis, 2010, 2(3):145-153. 
[7] Bruce IN, Urowitz MB, Gladman DD, et al. Natural history of hypercholester-olemi-a in systemic lupus erythematosus [J]. J Rheumatol, 1999, 26(11):2137-2143. 
[8] Hafiane A1, Kellett S, Genest J. Treatment options for low high-density lipoproteins [J]. Curr Opin Endocrinol Diabetes Obes, 2014, 21:134-139. 
[9] Ronda N, Favari E, Borghi MO, et al. Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus[J]. Ann Rheum Dis, 2014, 73: 609-615. 
[10] McMahon M, Skaggs BJ, Sahakian L, et al. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids[J]. Ann Rheum Dis, 2011, 70: 1619-1624. 
[11] McMahon M, Skaggs BJ, Grossman JM, et al. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus[J]. Arthritis Rheumatol, 2014, 66:130-139. 
[12] Hahn B. H, Grossman j, Ansel BJ. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis[J]. Arthritis Res Ther, 2008, 10(4): 213.

Downloads: 1922
Visits: 86342

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.